Title: Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
Journal: The Journal of biological chemistry 20151113
Title: EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
Journal: Nature 20121206
Title: Development and validation of reagents and assays for EZH2 peptide and nucleosome high-throughput screens.
Journal: Journal of biomolecular screening 20121201
Title: McCabe MT, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature. 2012 Dec 6;492(7427):108-12.
Title: Sato T, et al. PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer. Sci Rep. 2013 May 29;3:1911.